Literature DB >> 27994921

The Burden of Premature Mortality in Turkey in 2001 and 2008.

Burcu Tokuç1, Serap Ayhan1, Gamze Varol Saraçoğlu1.   

Abstract

BACKGROUND: Standard expected years of life lost (SEYLL) is a measure that is used to evaluate losses due to premature deaths. AIMS: The present study provides an analysis of premature mortality in Turkey for the years 2001 and 2008 and supplies evidence for making policies and setting health agendas over the long term. STUDY
DESIGN: Cross-sectional study.
METHODS: This study calculated SEYLL by gender, age group and causes of death in Turkey in 2014. The SEYLL measure counts the years lost in a population as a result of premature mortality and is computed by multiplying the number of deaths and standard life expectancy at the age at which death occurs.
RESULTS: The burden of premature mortality in Turkey was calculated as 4 104 253 SEYLL and 4 472 443 SEYLL in 2001 and 2008, respectively. Among these 42.7% and 43.9% of SEYLL were in females in 2001 and 2008, respectively. The leading five causes of premature mortality in the Turkish population in 2001 were cardiovascular system diseases (34.72%), perinatal conditions (12.69%), neoplasms (12.51%), external causes of injury (7.66%), and infections and parasitic diseases (6.57%). In 2008, the major causes were cardiovascular diseases (41.17%), neoplasms (14.63%), respiratory system diseases (9.81%), perinatal conditions (5.59%), and external causes of injury (5.29%).
CONCLUSION: The majority of the burden of premature mortality in Turkey is attributable to non-communicable diseases. While premature deaths from infections and parasitic diseases, perinatal conditions and congenital anomalies decreased between 2001 and 2008, deaths from cardiovascular diseases, neoplasms and respiratory system diseases increased dramatically. Coordinated efforts for effective national prevention programs (such as regular monitoring of adults for early diagnosis of cardiovascular diseases and for malignancies by family physicians) should be developed by policy makers to decrease preventable and premature deaths from non-communicable diseases.

Entities:  

Keywords:  Premature mortality; disease burden; standard expected years of life lost

Year:  2016        PMID: 27994921      PMCID: PMC5156462          DOI: 10.5152/balkanmedj.2016.151277

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  10 in total

1.  Progress and directions in refining the global burden of disease approach: a response to Williams.

Authors:  C J Murray; A D Lopez
Journal:  Health Econ       Date:  2000-01       Impact factor: 3.046

2.  How to measure the burden of mortality?

Authors:  L Bonneux
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

3.  Standard expected years of life lost as a measure of mortality: norms and reference to New Zealand data.

Authors:  Roger J Marshall
Journal:  Aust N Z J Public Health       Date:  2004-10       Impact factor: 2.939

4.  Years of potential life lost and productivity costs due to premature cancer-related mortality in Iran.

Authors:  Soheila Khorasani; Satar Rezaei; Hamideh Rashidian; Rajabali Daroudi
Journal:  Asian Pac J Cancer Prev       Date:  2015

5.  Trends in premature mortality due to chronic non-communicable diseases in Brazilian federal units.

Authors:  Carla Guimarães Alves; Otaliba Libânio de Morais Neto
Journal:  Cien Saude Colet       Date:  2015-03

6.  Years of life lost due to premature mortality in Italy.

Authors:  Sergio Mariotti; Paola D'Errigo; Simona Mastroeni; Karen Freeman
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

7.  Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2014-12-18       Impact factor: 79.321

8.  The burden of premature mortality in Spain using standard expected years of life lost: a population-based study.

Authors:  Ricard Gènova-Maleras; Ferrán Catalá-López; Nerea Fernández de Larrea-Baz; Elena Álvarez-Martín; Consuelo Morant-Ginestar
Journal:  BMC Public Health       Date:  2011-10-11       Impact factor: 3.295

9.  The burden of premature mortality in Poland analysed with the use of standard expected years of life lost.

Authors:  Irena Maniecka-Bryła; Marek Bryła; Paweł Bryła; Małgorzata Pikala
Journal:  BMC Public Health       Date:  2015-02-07       Impact factor: 3.295

10.  Quantifying the burden of disease due to premature mortality in Hong Kong using standard expected years of life lost.

Authors:  Dietrich Plass; Patsy Yuen Kwan Chau; Thuan Quoc Thach; Heiko J Jahn; Poh Chin Lai; Chit Ming Wong; Alexander Kraemer
Journal:  BMC Public Health       Date:  2013-09-18       Impact factor: 3.295

  10 in total
  2 in total

1.  Incidence and associated risk factors for premature death in the Tehran Lipid and Glucose Study cohort, Iran.

Authors:  Ali Eslami; Seyed Sina Naghibi Irvani; Azra Ramezankhani; Nazanin Fekri; Keyvan Asadi; Fereidoun Azizi; Farzad Hadaegh
Journal:  BMC Public Health       Date:  2019-06-10       Impact factor: 3.295

2.  Reflections on key methodological decisions in national burden of disease assessments.

Authors:  Elena von der Lippe; Brecht Devleesschauwer; Michelle Gourley; Juanita Haagsma; Henk Hilderink; Michael Porst; Annelene Wengler; Grant Wyper; Ian Grant
Journal:  Arch Public Health       Date:  2020-12-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.